The Wnt/β-catenin signalling pathway activates in 20%–35% of HCC cases (Jemal et al., 2010), primarily due to mutations in critical genes like CTNNB1, Axin, and APC (Xu et al., 2022). This evidence concerns the gene AXIN1 and hepatocellular carcinoma.